VetbiotechTM was established in 2022 as a subsidiary of AVB Biotech ®. It was established by AVB Biotech ® for the use, distribution and management of the signal therapy system developed for the first time in the world in the field of quantum biology in animal health.
Within the framework of the vision formed for this purpose, it is aimed to expand the scientific basis of this superior treatment system and spread it all over the world as it deserves.